Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(25%)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated125%
unknown250%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone

NCT07090122
unknownphase_2

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03058432
terminatedphase_2

Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma

NCT01667289
unknownphase_3

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

NCT00122746

Clinical Trials (4)

Showing 4 of 4 trials
NCT07090122Not Applicable

Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone

Recruiting
NCT03058432Phase 2

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Unknown
NCT01667289Phase 2

Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma

Terminated
NCT00122746Phase 3

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4